| Patent application number | Description | Published |
|---|
| 20140090950 | Bezel Assembly For Use with An Automated Transaction Device - The bezel assembly for data reception, for use with a bill validator in a financial transactional device, includes a bezel housing and a data reception assembly. The bezel housing includes a customer-facing front portion and a back plate connectable to the bill validator that is mounted within the transactional device cabinet. The front portion includes an insertion/dispensing slot for receiving currency and a projecting protrusion forward of the casing. The forward-extending protrusion accommodates at least a portion of the data reception assembly. The bezel assembly can include a wireless communication function that is communicably connectable with a mobile device via a wireless communication method, a manual entry function, a biometric reader, one or more cameras for scanning and decrypting 2D barcodes and the like, thus enhancing the overall functionality of the financial transactional device. | 04-03-2014 |
| 20140090951 | BEZEL ASSEMBLY FOR DATA RECEPTION - The bezel assembly for data reception, for use with a bill validator in a financial transactional device, includes a bezel housing and a data reception assembly. The bezel housing includes a customer-facing front portion and a back plate connectable to the bill validator that is mounted within the transactional device cabinet. The front portion includes an insertion/dispensing slot for receiving currency and a projecting hollow tongue forward of the casing. The forward-extending hollow tongue accommodates at least a portion of the data reception assembly. The bezel assembly can include a wireless communication function that is communicably connectable with a mobile device via a wireless communication method, a manual entry function, a biometric reader, one or more cameras for scanning and decrypting 2D barcodes and the like, thus enhancing the overall functionality of the financial transactional device. | 04-03-2014 |
| 20140090952 | Bezel Assembly Comprising Biometric Authentication For Use with An Automated Transaction Device - The bezel assembly for data reception, for use with a bill validator in a financial transactional device, includes a bezel housing and a data reception assembly. The bezel housing includes a customer-facing front portion and a back plate connectable to the bill validator that is mounted within the transactional device cabinet. The front portion includes an insertion/dispensing slot for receiving currency and a projecting protrusion forward of the casing. The forward-extending protrusion accommodates at least a portion of the data reception assembly. The bezel assembly can include a wireless communication function that is communicably connectable with a mobile device via a wireless communication method, a manual entry function, a biometric reader, one or more cameras for scanning and decrypting 2D barcodes and the like, thus enhancing the overall functionality of the financial transactional device. | 04-03-2014 |
| 20140090953 | Bezel Assembly Comprising Image Recognition For Use with An Automated Transaction Device - The bezel assembly for data reception, for use with a bill validator in a financial transactional device, includes a bezel housing and a data reception assembly. The bezel housing includes a customer-facing front portion and a back plate connectable to the bill validator that is mounted within the transactional device cabinet. The front portion includes an insertion/dispensing slot for receiving currency and a projecting protrusion forward of the casing. The forward-extending protrusion accommodates at least a portion of the data reception assembly. The bezel assembly can include a wireless communication function that is communicably connectable with a mobile device via a wireless communication method, a manual entry function, a biometric reader, one or more cameras for scanning and decrypting 2D barcodes and the like, thus enhancing the overall functionality of the financial transactional device. | 04-03-2014 |
| 20140360898 | Combination Cell Phone and Eyeglass Case - A trim, compact combination case dedicated to storing a cell phone (or other small electronic device) and an accessible pair of eyeglasses is disclosed. The combination cell phone and eyeglass case includes a phone housing compartment and an adjacent eyeglass/storage compartment, which are configured to hold a cell phone and eyeglasses side by side. An aspect includes a transparent access window by which a user can view and contact the front touchscreen of an enclosed phone. The compact design allows the combination case to be easily carried in a bag, purse, briefcase or pocket. The combination case advantageously positions the eyeglasses oriented and located for quick retrieval when needed to view the phone screen or buttons. | 12-11-2014 |
| Patent application number | Description | Published |
|---|
| 20110270448 | Irrigation Controller and System Integrating No-Watering Restrictions and an Empirically-Derived Evapotranspiration Local Characteristic Curve - A convenient, easy-to-use, water-saving, and labor-saving FROG irrigation controller and system are provided, which determine the appropriate water budget and schedule for the property's landscaping based on evapotranspiration data for the geographic area, regulation data (mandated and voluntary watering restrictions), and property-specific data (such as type of plant, zone number, emitter type, and plant environment), with consideration given to reduction in watering days, increase in soil watering depth, and day of year. Once set, the FROG provides incremental adjustments over the course of the year; the homeowner no longer needs to re-set the watering program seasonally to comply with local mandated and voluntary watering restrictions. Compliance is automatic and obligatory, meeting the water saving goals of the local water authority. Optionally presented is a web-based wizard used to determine a customized water budget/schedule that is input into the FROG controller through a data storage unit or wireless input. | 11-03-2011 |
| 20140088770 | Irrigation Controller and System Integrating No-Watering Restrictions and an Empirically-Derived Evapotranspiration Local Characteristic Curve - A convenient, water-saving and labor-saving FROG irrigation controller and system are provided, which determine the appropriate water budget and schedule for the property's landscaping based on evapotranspiration data for the geographic area, regulation data (any mandated and voluntary watering restrictions), and property-specific data, with consideration given to reduction in watering days, increase in soil watering depth, and day of year. Once set, the FROG controller provides incremental adjustments over the course of the year; the homeowner no longer needs to re-set the watering program seasonally to comply with local mandated and voluntary watering restrictions. Compliance is automatic and obligatory, meeting the water saving goals of the local water authority. Optionally presented is a web-based wizard used to determine a customized water budget/schedule that is input into the FROG controller through a data storage unit or wireless input. | 03-27-2014 |
| Patent application number | Description | Published |
|---|
| 20100143487 | BIOCOMPATIBLE PROTEIN-BASED PARTICLES AND METHODS THEREOF - The present invention relates to biocompatible protein-based particles and their methods of preparation and use. More specifically the present invention relates protein-based particles including protein matrix, spread matrix and/or biocoacervate materials derived from one or more biocompatible purified proteins combined with one or more biocompatible solvents that are used to replace or repair tissue and/or bone in treatments for spinal disc(s), joint(s) (e.g. knee, hip, finger, ankle, elbow, shoulder . . . ) and organ(s) (e.g. bladder, lips, vagina, penis, urethra . . . ). In various embodiments of the present invention the protein-based particles may also include one or more pharmacologically active agents and/or one or more additives. | 06-10-2010 |
| 20100196478 | PROTEIN MATRIX MATERIALS, DEVICES AND METHODS OF MAKING AND USING THEREOF - The present invention relates to protein matrix materials and devices and the methods of making and using protein matrix materials and devices. More specifically the present invention relates to protein matrix materials and devices that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, encapsulated or coated stent devices, vessels, tubular grafts, vascular grafts, wound healing devices including protein matrix suture material and meshes, skin/bone/tissue grafts, biocompatible electricity conducting matrices, clear protein matrices, protein matrix adhesion prevention barriers, cell scaffolding and other biocompatible protein matrix devices. Furthermore, the present invention relates to protein matrix materials and devices made by forming a film comprising one or more biodegradable protein materials, one or more biocompatible solvents and optionally one or more pharmacologically active agents. The film is then partially dried, rolled or otherwise shaped, and then compressed to form the desired protein matrix device. | 08-05-2010 |
| 20110118818 | ENCAPSULATED OR COATED STENT SYSTEMS - A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents. | 05-19-2011 |
| 20120041539 | PROTEIN BIOMATERIAL AND BIOCOACERVATE VESSEL GRAFT SYSTEMS AND METHODS OF MAKING AND USING THEREOF - The present invention relates to protein biocoacervates and biomaterials vessel graft systems used in cardiovascular applications and other medical applications, the components utilized in the vessel graft systems and the methods of making and using such systems. More specifically the present invention relates to protein biocoacervates and biomaterials vessel graft systems used in various medical applications and/or the devices used in such vessel graft systems including, but not limited to, vessel grafts as drug delivery devices for the controlled release of pharmacologically active agents, tubular grafts, vascular grafts, protein biomaterial sutures and biomeshes, protein biomaterial adhesives and glues, and other biocompatible biocoacervate or biomaterial devices used in the vessel graft systems of the present invention. | 02-16-2012 |
| 20120282300 | PROTEIN BIOMATERIALS AND BIOCOACERVATES AND METHODS OF MAKING AND USING THEREOF - The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices. | 11-08-2012 |
| 20140107227 | MUCOADHESIVE DRUG DELIVERY DEVICES AND METHODS OF MAKING AND USING THEREOF - The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue. | 04-17-2014 |
| 20140330252 | BIOMATRIX STRUCTURAL CONTAINMENT AND FIXATION SYSTEMS AND METHODS OF USE THEREOF - The containment and fixation system of the present invention generally includes a biomatrix sleeve, biomatrix particles or combinations thereof made of a biomatrix material. The biomatrix material is comprised of one or more biocompatible proteins and one or more biocompatible solvents. The biomatrix material utilized in the sleeve and/or particles may also include one or more pharmacologically active agents like therapeutic biochemicals such as a bone mending biochemical (e.g. hydroxyapatite) or an angiogenic growth factor (e.g. BMP). | 11-06-2014 |
| Patent application number | Description | Published |
|---|
| 20110223226 | SHELF STABLE CAPSULES - A capsule slury including at least one coacervated capsule and at least 10 wt % humectant is disclosed. The humectant may be sorbitol, glycerin, polyethylene glycol, propylene glycol, xylitol, erythritol and/or betaine. | 09-15-2011 |
| 20120100193 | ORAL COMPOSITIONS AND USES THEREOF - The present invention is directed to oral compositions comprising an orally-acceptable carrier and a silica abrasive comprising a precipitated amorphous silica compound having an average particle size of from 5 μm to 20 μm, oil absorption of from 60 cc/100 g to 120 cc/100 g, and an Einlehner hardness of from 4 to 11, and methods of use thereof | 04-26-2012 |
| 20120201762 | ORAL CARE COMPOSITION - Disclosed are oral care compositions and the use of such oral care compositions for treating or preventing oral malodor. Also disclosed are methods for treatment or prevention of oral malodor. The oral care compositions include serine in an amount effective to reduce oral malodor caused by hydrogen sulfide and/or indole. | 08-09-2012 |
| 20120251466 | ANTI-EROSION TOOTHPASTE COMPOSITION - Disclosed herein are oral care compositions comprising a fluoride ion source and phosphate salts, and methods of making and using the same. | 10-04-2012 |
| 20120282313 | HIGH CLEANING AND LOW ABRASION SILICA MATERIALS TO MODULATE ENTRAPMENT AND RELEASE OF HYDROPHOBIC ACTIVES IN DENTAL FORMULATIONS - Described herein are compositions which modulate entrapment and release of flavorants and other actives in dental formulations. | 11-08-2012 |
| 20120288547 | STABILIZATION OF ZINC OXIDE FILM IN ORAL COMPOSITIONS - An oral care composition and method are described in which the composition includes a film or a plurality of film fragments entrained in a carrier. The film or plurality of film fragments comprises zinc oxide. The composition and methods provide benefits including increased stability and shelf-life ensuring the delivery and bioavailability of zinc oxide. | 11-15-2012 |
| 20120308491 | DENTIFRICE COMPOSITIONS - Described herein are dentifrice compositions comprising a zinc-containing salt and carboxypeptidase, wherein the zinc-containing salt is not sequestered. | 12-06-2012 |
| 20130251645 | Oral and Personal Care Compositions - Described herein are films comprising a zinc-containing compound and a film-stabilizing ingredient, for use in oral and personal care compositions. | 09-26-2013 |
| 20140314689 | THYMOL AND TOTAROL ANTIBACTERIAL COMPOSITION - An antibacterial composition comprising thymol and totarol. This combination provides synergistic effect against gram negative and gram positive bacteria. | 10-23-2014 |
| 20140328772 | SOLUBILIZED MAGNOLOL ANALOGS - A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti -bacterial activity and reducing the expression of pro-inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate. | 11-06-2014 |
| 20140341818 | SOLUBILIZED MAGNOLOL ANALOGS - A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and dimethyl isosorbide. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators. | 11-20-2014 |
| 20140342968 | CLEANSING COMPOSITIONS WITH POLYURETHANE-34 - A cleansing composition comprising a cleansing effective amount of surfactant and polyurethane-34. The polyurethane-34 can deposit on skin during cleansing and form a barrier that reduces bacterial attachment to skin. | 11-20-2014 |
| 20140348761 | SOLUBILIZED MAGNOLOL ANALOGS - A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and PPG-1-PEG-9 lauryl glycol ether. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators. | 11-27-2014 |
| Patent application number | Description | Published |
|---|
| 20080213195 | Antibacterial Dentifrice Exhibiting Antiplaque and Breath Freshening Properties - A dual component antiplaque oral composition having antimalodor properties in which a first component contains an antibacterial agent and the second component contains a proteolytic enzyme, the first and second components are simultaneously combined for application to the teeth, the first and second components being physically segregated prior to use, the components when mixed upon application to teeth providing substantially antiplaque effect with superior antimalodor properties. | 09-04-2008 |
| 20080242767 | Polymeric Encapsulates Having a Quaternary Ammonium Salt and Methods for Producing the Same - A quaternary ammonium salt encapsulated by a polymeric microcapsule and methods for manufacturing such microcapsules are described. The quaternary ammonium salt can be cetylpyridinium chloride. The polymeric microcapsule encapsulating the quaternary ammonium salt can be used as an ingredient in a dentifrice. | 10-02-2008 |
| 20080292692 | Impermeable Capsules - A capsule comprising a core and a shell surrounding and enclosing the core, the shell comprising at least one first polymer having a first water solubility parameter, and at least one second polymer having a water solubility parameter higher than the first water solubility parameter, wherein the second polymer is crosslinked, and/or all of the at least one second polymer is present in an amount that is less than all of the at least one first polymer. Upon exposure to an aqueous medium, the first polymer begins to swell, and water begins to leak into the capsule. Also, the second polymer is attracted to the entering water. As the second polymer absorbs water and swells, the mean free space in the shell decreases and the tortuous pathway for materials crossing the boundary of the wall increases. As a result, leakage rates across the capsule wall decrease. | 11-27-2008 |
| 20100266514 | Dual Component Dental Composition Containing Enzyme - A two component desensitizing dentifrice composition is disclosed which comprises a first dentifrice component containing an enzyme such as papain and a second dentifrice component containing an ionic surfactant such as sodium lauryl sulfate, the first and second dentifrice components being maintained separate from the other until dispensed for application to teeth whereby enzyme activity is maintained with improved dentifrice foaming characteristics. | 10-21-2010 |
| 20120141388 | ANTIBACTERIAL DENTIFRICE EXHIBITING ENHANCED ANTIPLAQUE AND BREATH FRESHENING PROPERTIES - An abrasive dentifrice composition which effects enhanced antiplaque and breath freshening properties which comprises an orally acceptable vehicle containing a combination of a safe and effective amount of an antibacterial agent and at least two enzyme ingredients. | 06-07-2012 |
| 20120269742 | ENZYME ENHANCED BREATH FRESHENING FILM - An orally consumable film composition for delivering breath freshening agents to the oral cavity which is rapidly dissolvable or dispersible in the oral cavity, the composition being comprised of a homogeneous mixture of a water dispersible film forming polymer and an enzyme. | 10-25-2012 |
| 20130280186 | Polymer Systems - Disclosed herein are polymer systems and compositions comprising polymer systems, and methods of preparing and using the same. | 10-24-2013 |
| 20140170086 | Method for Indicating Time for Washing or Indicating Delivery of Antibacterial Agent - A method for indicating release of an antibacterial agent or for indicating an amount of time for cleansing skin with an aqueous cleansing composition comprising a surfactant and a zinc X halide complex, wherein X is an amino acid or trimethylglycine, wherein the method comprises washing skin with the cleansing composition and water for a time until the zinc X halide complex precipitates from the aqueous cleansing composition. | 06-19-2014 |
| Patent application number | Description | Published |
|---|
| 20090047222 | Color Stable Peroxide Containing Dentifrice Formulations With Dye Encapsulated Silica Shell Nanoparticles - A composition for minimizing color fading of an oral care composition is provided. The composition comprises: a) an organic dye-encapsulated silica shell nanoparticle matrix, b) a physiologically stable fluoride ion providing compound in an amount of about 0.1% to about 1% by weight, c) a peroxide species providing compound in an amount of about 1% to to about 20% by weight. The encapsulated silica shell dye nanoparticle stabilizes the color against degradation in the presence of peroxide and fluoride ions. | 02-19-2009 |
| 20090068122 | Dentifrice Compositions for Treating Xerostomia - This invention encompasses an oral composition for treating or preventing dry mouth with following benefits: antibacterial/anti-fungal efficacy, low irritancy, and moisture retention. The compositions can be a toothpaste, a mouth rinse or a spray and include one or more non-ionic surfactants, as foaming agents, one or more broad spectrum anti-microbial ingredient, such as chlorhexidine and cetylpyridinium chloride, and one or more oral surface adhesive polysaccharides that can encage cationic actives to help the deposition and retention of the agents onto oral surfaces and thus provide antimicrobial efficacy. | 03-12-2009 |
| 20090068259 | Controlled Surface Gelling of Mucoadhesive Polymers on Oral Mucosa - The present invention relates to an oral composition and method for alleviating the symptoms associated with xerostomia using encapsulated cation-releasing compounds formulated either intimately together or in separate compartments in a composition containing cation-sensitive mucoadhesive polymers. | 03-12-2009 |
| 20120027696 | DENTIFRICE COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING DAMAGE TO TOOTH SURFACES - The invention encompasses compositions and methods for treating and modifying surfaces of teeth, which compositions include calcium and magnesium containing silicates or silica, cationic polymer modified silica or combinations thereof. The composition when applied to the teeth or a tooth surface deposit on such surfaces to repair acid damaged enamel and prevent further erosion of a tooth surface. | 02-02-2012 |
| 20120045495 | HIGHER LOADING ZINC-CONTAINING FILMS - Described herein are polymer matrix films, compositions comprising the polymer matrix films, and methods of preparing and using the same. | 02-23-2012 |
| 20120308488 | ORAL CARE PRODUCT FOR SENSITIVE ENAMEL CARE - Disclosed are anti-erosion oral care formulations and methods that provide erosion protection while maintaining adequate cleaning performance. The anti-erosion oral care formulations include a mucoadhesive polymer and a zinc compound or salt that becomes more soluble at acidic pH. | 12-06-2012 |
| 20140340676 | Method for Assessing Perspiration Reduction - A method to assess perspiration reduction of a composition comprising obtaining an amount of water in stratum corneum in a first area of skin on an individual using confocal Raman spectroscopy, applying a composition to the first area of skin on the individual, having the individual perform an activity to cause the individual to perspire, and obtaining an amount of water in stratum corneum in the first area of skin on the individual after the activity using confocal Raman spectroscopy. | 11-20-2014 |
| Patent application number | Description | Published |
|---|
| 20080268551 | System and Method for Biological Assays - The present invention provides polymers and microfluidic devices comprising a covalently attached substrate binding element, and methods for producing and using the same. | 10-30-2008 |
| 20080293906 | BIOACTIVE AND BIOCOMPATIBLE POLYURETHANE-BUTHANEDIOL-GLYCOSAMINOGLYCAN SALT COPOLYMERS - A bioactive and biocompatible polyurethane-butanediol-glycosaminoglycan copolymer for use in medical implant devices. The biocompatible urethane component being the reaction product of 4,4′-methylene-di-(p-phenyl isocyanate) and poly(tetramethylene oxide)n and further reacted with 1,4-butanediol, wherein n=10 to 40. The bioactive glycosaminoglycan being a salt of hyaluronic acid, such as a cetylpyridinium salt acid having 5 to 10,000 repeating units or a salt of heparin, such as a dimethyldioctadecylammonium salt of heparin has 5 to 65 repeating units or a suitable salt of dermatan sulfate. The weight content of the bioactive glycosaminoglycan is an amount sufficient to render the copolymer bioactive. The copolymers described herein have excellent hemocompatibility and biocompatibility. | 11-27-2008 |
| 20090062834 | ANEURYSM OCCLUSION DEVICE CONTAINING BIOACTIVE AND BIOCOMPATIBLE COPOLYMER SHELL AND BIOCOMPATIBLE METALLIC FRAME MEMBER - An endovascular device for occluding a vascular aneurysm is disclosed. The device includes a polymeric shell member that, in one embodiment, may be constructed from a bioactive and biocompatible polyurethane-diol-glycosaminoglycan copolymer, and a biocompatible metallic frame member. The copolymer is sufficiently flexible and strong for endovascular delivery into a vascular aneurysm and for use as a polymeric shell for receiving the biocompatible metallic frame member. The biometallic frame member may include one or more components constructed from a NiTi alloy. | 03-05-2009 |
| 20090118761 | ANEURYSM OCCLUSION DEVICE CONTAINING BIOACTIVE AND BIOCOMPATIBLE COPOLYMER SHELL AND A LIQUID EMBOLIC AGENT - An endovascular device for occluding a vascular aneurysm is disclosed. The device includes a polymeric shell member that, in one embodiment, may be constructed from a bioactive and biocompatible polyurethane-diol-glycosaminoglycan copolymer, and a liquid embolic agent. The copolymer is sufficiently flexible and strong for endovascular delivery into a vascular aneurysm and for use as a polymeric shell for receiving the liquid embolic agent. Upon activation inside of the polymeric shell within the aneurysm, the liquid embolic agent solidifies enabling biological isolation of the aneurysm and improved patient outcomes. | 05-07-2009 |
| Patent application number | Description | Published |
|---|
| 20140150709 | System for Preventing Undue Bending of Cables - A cable system is disclosed including a central cable; an inner membrane having a higher minimum bend radius than the central cable and surrounding the cable, thereby forming an inner chamber around the central cable, the inner chamber containing a gas or at least one chemical; and an outer membrane surrounding the inner membrane and forming an outer chamber around the inner chamber, the outer chamber comprising a gas or at least one chemical. When the minimum bend radius of the inner membrane is exceeded, the inner membrane fractures or breaks, and the gas or at least one chemical from the inner chamber enters the outer chamber to create a chemiluminescence reaction, color, or smell. | 06-05-2014 |
| 20140150710 | System for Preventing Undue Bending of Cables - A cable system is disclosed including a central cable; an inner membrane having a higher minimum bend radius than the central cable and surrounding the cable, thereby forming an inner chamber around the central cable, the inner chamber containing a gas or at least one chemical; and an outer membrane surrounding the inner membrane and forming an outer chamber around the inner chamber, the outer chamber comprising a gas or at least one chemical. When the minimum bend radius of the inner membrane is exceeded, the inner membrane fractures or breaks, and the gas or at least one chemical from the inner chamber enters the outer chamber to create a chemiluminescence reaction, color, or smell. | 06-05-2014 |
| 20140372335 | Cooperative Path Tracking - An approach is provided in which a tracking device is attached to an object and receives nearby object routes from multiple nearby tracking devices, each attached to respective nearby objects. The tracking device compares an expected route corresponding to the object with the received nearby object routes to determine whether the object is being transported along the expected route. When the tracking device determines that the object has been incorrectly routed, the tracking device generates a notification. | 12-18-2014 |
| Patent application number | Description | Published |
|---|
| 20120015808 | SYNERGISTIC HERBICIDAL COMPOSITIONS CONTAINING AMINOPYRALID, 2,4-DICHLOROPHENOXYACETIC ACID AND ATRAZINE - An herbicidal composition containing (a) aminopyralid and 2,4-D and (b) atrazine provides synergistic control of selected weeds in corn, sorghum, sugar cane and range and pasture. | 01-19-2012 |
| 20130143738 | HERBICIDAL COMPOSITION CONTAINING CERTAIN PYRIDINE CARBOXYLIC ACIDS AND (2,4-DICHLOROPHENOXY)ACETIC ACID - Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid (I) or a derivative thereof and 2,4-D or a derivative thereof. | 06-06-2013 |
| 20130143739 | HERBICIDAL COMPOSITION CONTAINING 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or derivative thereof AND FLUROXYPYR or derivatives thereof - Herbicidal compositions comprising and methods of controlling desirable vegetation utilizing 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or an agriculturally acceptable ester, amide, or salt thereof and (b) fluroxypyr or an agriculturally acceptable ester, amide, or salt thereof. | 06-06-2013 |
| 20140066305 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND CLOPYRALID - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) clopyralid, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) clopyralid, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 03-06-2014 |
| 20140094364 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND AMINOPYRALID - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) aminopyralid, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) aminopyralid, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 04-03-2014 |
| 20140094365 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND TRICLOPYR - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) triclopyr, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) triclopyr, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 04-03-2014 |
| 20140094366 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND FLUROXYPYR - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) fluoroxypyr, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) fluoroxypyr, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 04-03-2014 |
| 20140171318 | Synergistic Weed Control From Applications of Aminopyralid And Clopyralid - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminopyralid, or an agriculturally acceptable salt or ester thereof, and (b) clopyralid, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminopyralid, or an agriculturally acceptable salt or ester thereof, and (b) clopyralid, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 06-19-2014 |
| Patent application number | Description | Published |
|---|
| 20100016198 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them - Compositions comprising sulfo-estolides and alkyl ester sulfonates are described. Detergent formulations, such as laundry detergents, softeners, and other materials, containing any of these materials are disclosed, as well as personal care formulations, hard surface cleaner formulations, and automatic dishwasher detergent formulations. Laundry methods employing these formulations are also disclosed. These formulations are useful as laundry detergents and can be biodegradable, heavy duty liquids, 2× or 3× and up to 6× concentrates, low foaming, and/or effective in a high efficiency washing machine. Methods for laundering fabrics with the compositions are also disclosed. | 01-21-2010 |
| 20100184632 | Automatic or Machine Dishwashing Compositions of Sulfonated Estolides and Other Derivatives of Fatty Acids and Uses Thereof - Sulfo-estolides and methods of making them are described. Useful methods include acid side bleaching, partial hydrogenation of the fatty acid, pretreatment of the fatty acid to provide color inhibition, acid side hydrolysis of the sulfo-estolides, or conversion of SHP to an essentially fully hydrolyzed product (HSHP) or a partially hydrolyzed product (PHSHP). Formulations and concentrated formulations of automatic dishwasher detergent or machine wash detergent compositions containing sulfo-estolides, among others, are also included. | 07-22-2010 |
| 20100184633 | Light Duty Liquid Detergent Compositions of Sulfonated Estolides and Other Derivatives of Fatty Acids and Uses Thereof - Light duty liquid detergent formulations that contain sulfo-estolide surfactants, sulfo-estolide derivatives and salts of sulfo-estolides are disclosed. The compositions of the presently described technology are useful for soil removal applications including, but not limited to, washing dishes by hand. | 07-22-2010 |
| 20120129955 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them - Compositions comprising sulfo-estolides and alkyl ester sulfonates are described. Detergent formulations, such as laundry detergents, softeners, and other materials, containing any of these materials are disclosed, as well as personal care formulations, hard surface cleaner formulations, and automatic dishwasher detergent formulations. Laundry methods employing these formulations are also disclosed. These formulations are useful as laundry detergents and can be biodegradable, heavy duty liquids, 2× or 3× and up to 6× concentrates, low foaming, and/or effective in a high efficiency washing machine. | 05-24-2012 |
| 20130225408 | FATTY AMINES, AMIDOAMINES, AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS - Fatty amine compositions made from a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives are disclosed. In another aspect, fatty amidoamines made by reacting a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives with an aminoalkyl-substituted tertiary amine are disclosed. The fatty amines or amidoamines are advantageously sulfonated, sulfitated, oxidized, or reduced. In other aspects, the ester derivative is a modified triglyceride made by self-metathesis of a natural oil or an unsaturated triglyceride made by cross-metathesis of a natural oil with an olefin. | 08-29-2013 |
| 20130225409 | QUATERNIZED FATTY AMINES, AMIDOAMINES AND THEIR DERIVATIVES FROM NATURAL OIL METATHESIS - Quaternary ammonium, betaine, or sulfobetaine compositions derived from fatty amines, wherein the fatty amine is made by reducing the amide reaction product of a metathesis-derived C | 08-29-2013 |
| 20130225469 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS - Aqueous hard surface cleaner compositions derived from metathesized natural oil feedstocks are disclosed. In one aspect, the compositions comprise at least one anionic surfactant derived from a metathesis-derived C10-C17 monounsaturated acid, 5 octadecene-1,18-dioic acid, or their ester derivatives. In another aspect, aqueous hard surface cleaners comprising at least one nonionic or amphoteric surfactant derived from a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives are disclosed. The aqueous cleaners noted above rival or outperform commercial baselines in a Gardner straight-line washability test. Industrial degreasers comprising a C10 or C12 amide solvent and derived from a metathesis-derived C10-C17 monounsaturated acid are superior to commercial standards. | 08-29-2013 |
| 20130225470 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS - Fatty amide compositions and their derivatives are disclosed. The fatty amides comprise a reaction product of a metathesis-derived C | 08-29-2013 |
| 20130225473 | SULFONATES FROM NATURAL OIL METATHESIS - Sulfonate compositions are disclosed. The compositions include alkanesulfonates, alkenesulfonates, sultones, and hydroxy-substituted alkanesulfonates. The sulfonates comprise a reaction product of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives with a sulfonating or sulfitating agent. In one aspect, the sulfonate composition is a sulfo-estolide made by reacting a metathesis-derived C10-C17 monounsaturated acid or octadecene-1,18-dioic acid with a sulfonating agent, optionally in the presence of a saturated fatty acid. The sulfonates are valuable for a wide variety of end uses, including cleaners, fabric treatment, hair conditioning, personal care (liquid cleansing products, conditioning bars, oral care products), paint additives, antimicrobial compositions, agricultural uses, and oil field applications. | 08-29-2013 |
| 20130225859 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS - Esteramine compositions and their derivatives are disclosed. The esteramines comprise a reaction product of a metathesis-derived C | 08-29-2013 |
| 20140005423 | ALKOXYLATED FATTY ESTERS AND DERIVATIVES FROM NATURAL OIL METATHESIS | 01-02-2014 |
| 20150087521 | UNSATURATED FATTY ALCOHOL DERIVATIVES FROM NATURAL OIL METATHESIS - Sulfate and sulfonate derivatives of unsaturated fatty alcohols, processes for making them, and methods of using them are disclosed. In one aspect, a monounsaturated fatty alcohol composition is made by reducing a metathesis-derived monounsaturated alkyl ester. The fatty alcohol composition is then converted to a sulfate or sulfonate derivative by one or more of alkoxylation, sulfation, sulfonation, and sulfitation. Of particular interest are the sulfate and ether sulfate derivatives. | 03-26-2015 |
| 20150087724 | UNSATURATED FATTY ALCOHOL ALKOXYLATES FROM NATURAL OIL METATHESIS - Unsaturated fatty alcohol alkoxylates, processes for making them, and methods of using them are disclosed. In one aspect, a monounsaturated fatty alcohol alkoxylate is made by reducing a metathesis-derived monounsaturated alkyl ester, followed by alkoxylation of the resulting monounsaturated alcohol. Microscopy reveals that the monounsaturated alkoxylates have isotropic and lamellar phases over a wider range of actives levels compared with their saturated analogs. This attribute expands formulating latitude for many end-use applications. The unsaturated fatty alcohol alkoxylates are valuable in, for example, agricultural solvents, nonionic emulsifiers for agricultural compositions, hard surface cleaners, laundry detergents, specialty foams, additives or surfactants for paints or coatings, and surfactant compositions for enhanced oil recovery. | 03-26-2015 |
| Patent application number | Description | Published |
|---|
| 20120287430 | HIGH RESOLUTION SLIT-FREE DIRECT-VIEWING MULTIPLEXING FIELD SPECTROGRAPH - A compact field spectrograph is described that provides a resolution of 500 or more with no entrance aperture, providing for substantial gain in light throughput, ideal for viewing multiple distant objects with or without telescopic aid, and providing the ability to observe and distinguish a multiplex of objects simultaneously, even if in motion, with minimal or no mechanical tracking required. Spectra may be viewed directly with the unaided eye, or photographed with common consumer cameras. | 11-15-2012 |
| 20120295831 | FOAMING LIGHT DUTY LIQUID DETERGENT COMPOSITIONS, METHODS OF MAKING AND USES THEREOF - Foaming light duty liquid detergent formulations that contain at least one cleaning solvent, at least one anionic surfactant and at least foam stabilizing surfactant are disclosed. The compositions of the presently described technology are useful for soil removal applications including, but not limited to, washing dishes by hand and cleaning bathroom and kitchen articles and/or surfaces. | 11-22-2012 |
| 20140038874 | MULTI-ARM HYDROPHILIC URETHANE POLYMERS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM - Hydrophilic, multi-arm urethane polymers are described that are dispersible and/or soluble in water, and provide wetting, foaming and cleaning benefits for aqueous cleaning products, including hard surface cleaners, machine dishwash, and liquid hand dishwash compositions. | 02-06-2014 |
| Patent application number | Description | Published |
|---|
| 20100324652 | Sealing Device and Delivery System - The invention relates to a sealing device for repair of cardiac and vascular defects or tissue opening such as a patent foramen ovale (PFO) or shunt in the heart, the vascular system, etc. and particularly provides an occluder device and trans-catheter occluder delivery system. The sealing device would have improved conformity to heart anatomy and be easily deployed, repositioned, and retrieved at the opening site. | 12-23-2010 |
| 20120029556 | SEALING DEVICE AND DELIVERY SYSTEM - The invention relates to a sealing device for repair of cardiac and vascular defects or tissue opening such as a patent foramen ovale (PFO) or shunt in the heart, the vascular system, etc. and particularly provides an occluder device and trans-catheter occluder delivery system. The sealing device would have improved conformity to heart anatomy and be easily deployed, repositioned, and retrieved at the opening site. | 02-02-2012 |
| 20120143242 | Sealing Device and Delivery System - The invention relates to a sealing device for repair of cardiac and vascular defects or tissue opening such as a patent foramen ovale (PFO) or shunt in the heart, the vascular system, etc. and particularly provides an occluder device and trans-catheter occluder delivery system. The sealing device would have improved conformity to heart anatomy and be easily deployed, repositioned, and retrieved at the opening site. | 06-07-2012 |
| 20120172927 | LEFT ATRIAL APPENDAGE OCCLUSIVE DEVICES - An occlusive device for left atrial appendage occlusion that has a membrane component configured to inhibit passage of blood and an expandable frame formed from a plurality of wires having a cupped occlusive component at least partially covered with the membrane component, one or more anchors with looped ends and a hub component. The occlusive device can be delivered percutaneously. The occlusive device is useful in the occlusion of the left atrial appendage. | 07-05-2012 |
| 20130041404 | Heart Occlusion Devices - Devices for occluding an aperture in tissue or a vessel comprise a first flexible wire and a second flexible wire. Each of the first and second wires is comprised of a shape memory material. Each of the first and second wires is shaped into first and second geometric forms such that the first geometric form of the first wire and the first geometric form of the second wire form a first plate in a first plane, and the second geometric form of the first wire and the second geometric form of the second wire form a second plate in a second plane that is parallel to and remote from the first plane. The first and second plates are separated by a waist formed from two portions of the first wire and two portions of the second wire. Methods for occluding an aperture in tissue or a vessel using such devices are also provided. | 02-14-2013 |
| 20130165967 | HEART OCCLUSION DEVICES - This disclosure is directed to an aperture occlusion device and a method for occluding an aperture, including a perimembranous ventricular septal defect. The aperture occlusion device includes a wire frame element. The wire frame forms geometric shapes that include an occluder region and a securing region. The occluder region and the securing region are separated by an attachment region including a waist. The occluder region and securing region can include membranous coverings. The device can be attached to a delivery hub. The wires forming the occluder region and securing region can have a shape-memory capability such that they can be collapsed and distorted in a sheath during delivery, but resume and maintain their intended shape after delivery. | 06-27-2013 |
| 20130231684 | SEALING DEVICE AND DELIVERY SYSTEM - The invention relates to a sealing device for repair of cardiac and vascular defects or tissue opening such as a patent foramen ovale (PFO) or shunt in the heart, the vascular system, etc. and particularly provides an occluder device and trans-catheter occluder delivery system. The sealing device would have improved conformity to heart anatomy and be easily deployed, repositioned, and retrieved at the opening site. | 09-05-2013 |
| 20130245666 | OCCLUSIVE DEVICES - An occlusive device includes a frame element having a distal end and a proximal end, and a delivery configuration and a deployed configuration. The occlusive device also includes an occlusive face having a peripheral edge, where the occlusive face positioned toward the proximal end of the frame element. The occlusive device also includes at least one anchor positioned at the peripheral edge of the occlusive face, where the at least one anchor extends at an acute angle to the peripheral edge of the occlusive face. | 09-19-2013 |
| 20140142610 | Space Filling Devices - A device includes a plurality of elongate members, an occlusive component, and a support component. The occlusive component includes a plurality of first features each defined by a first portion of a respective elongate member. The support component includes a plurality of second features each defined by a second portion of the respective elongate member. A first termination element is defined by proximal end portions of the plurality of elongate members and located near a proximal end of the device, and a second termination element is defined by distal end portions of the plurality of elongate members and located near a distal end of the device. One or more anchor elements include a frame attachment portion and an anchor portion, the frame attachment portion including a first portion of a fixation elongate element wrapped around an elongate member, and the anchor portion including an anchor feature. | 05-22-2014 |
| 20140142617 | JOINT ASSEMBLY FOR MEDICAL DEVICES - A device for occluding an aperture in a body of a patient includes a frame that includes a plurality of elongate members and a hub component that includes a plurality of attachment members, wherein for each elongate member of the plurality of elongate members a first end of the elongate member is fixedly attached to an attachment member of the plurality of attachment members at an attachment region. The frame and the hub component together form at least one occlusive element. Each receptacle of the plurality of attachment members is configured to pivot with respect to the hub component, such that each attachment region is movable with respect to the hub component. | 05-22-2014 |
| 20140142621 | IMPLANTABLE MEDICAL DEVICE DEPLOYMENT SYSTEM - A medical device delivery system includes an implantable medical device and a delivery device. The implantable medical device includes at least one attachment feature having an elastomeric element. The delivery device includes a catheter and an elongate element. The catheter is arranged to contact the elastomeric element, and the elongate element is arranged to releasably couple with the elastomeric element. | 05-22-2014 |
| 20140207185 | Sealing Device and Delivery System - A medical device for sealing a defect in a body includes a wire frame that includes a plurality of wires that form a first occluding member and a second occluding member, the wire frame including a defect-occupying portion disposed between the first occluding member and the second occluding member. The defect-occupying portion is adapted to fill a wide range of potential defect sizes, such that no more than five devices of a range of sizes are required to effectively seal a range of nominal defect sizes of approximately 8 to 35 mm. | 07-24-2014 |
| 20140379019 | OCCLUSIVE DEVICES - An occlusive device includes a frame element having a distal end and a proximal end, and a delivery configuration and a deployed configuration. The occlusive device also includes an occlusive face having a peripheral edge, where the occlusive face positioned toward the proximal end of the frame element. The occlusive device also includes at least one anchor positioned at the peripheral edge of the occlusive face, where the at least one anchor extends at an acute angle to the peripheral edge of the occlusive face. | 12-25-2014 |
| 20140379020 | LEFT ATRIAL APPENDAGE OCCLUSIVE DEVICES - An occlusive device for left atrial appendage occlusion that has a membrane component configured to inhibit passage of blood and an expandable frame formed from a plurality of wires having a cupped occlusive component at least partially covered with the membrane component, one or more anchors with looped ends and a hub component. The occlusive device can be delivered percutaneously. The occlusive device is useful in the occlusion of the left atrial appendage. | 12-25-2014 |
